Cardiff Oncology, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €87.46M +25,277.5% -€43.64M -62.1% -49.9% +330 pp N/A N/A
    (estimated) €344.62K +207.7% -€115.17M +46.0% -33,420.0% +370 pp N/A N/A
    (estimated) €112.00K -60.6% -€78.88M +41.1% -70,430.8% -510 pp N/A N/A
    (estimated) €284.31K -21.4% -€55.92M +15.5% -19,669.7% -63 pp N/A N/A
    (estimated) €361.85K -38.5% -€48.44M +23.7% -13,385.7% -67 pp N/A N/A
    €588.44K +40.0% -€39.14M +9.6% -6,651.7% +18 pp -€32.41M +24.1% -5,507.0% +7.0 pp
    €420.44K +26.4% -€35.70M +10.5% -8,492.0% +12 pp -€26.11M -8.0% -6,210.0% +23 pp
    €332.56K +7.5% -€32.31M +35.2% -9,716.6% -20 pp -€28.37M +44.2% -8,530.6% -22 pp
    €309.30K -1.9% -€23.90M +43.9% -7,727.6% -25 pp -€19.67M +41.8% -6,360.7% -20 pp
    €315.32K +49.4% -€16.61M +19.4% -5,267.8% +13 pp -€13.87M +22.0% -4,399.8% +9.9 pp
    €211.08K -35.2% -€13.92M -1.9% -6,592.7% -22 pp -€11.37M +0.0% -5,387.8% -19 pp
    €325.67K -25.1% -€14.18M -33.9% -4,354.8% +5.8 pp -€11.37M -43.1% -3,490.7% +11 pp
    €435.08K +32.5% -€21.46M -36.5% -4,932.1% +54 pp -€19.97M -23.3% -4,590.3% +33 pp
    €328.25K +21.7% -€33.78M +42.7% -10,289.8% -15 pp -€26.03M +52.0% -7,931.0% -16 pp
    €269.66K +11.8% -€23.67M +91.8% -8,776.7% -37 pp -€17.13M +60.8% -6,350.8% -19 pp
    €241.23K +8.0% -€12.34M +21.3% -5,116.1% -5.6 pp -€10.65M +85.4% -4,415.7% -18 pp
    €223.35K -42.4% -€10.18M +2.1% -4,555.9% -20 pp -€5.74M +42.9% -2,572.1% -15 pp
    €387.70K +74.6% -€9.96M +416.5% -2,570.2% -17 pp -€4.02M +141.8% -1,036.6% -2.9 pp
    €222.02K -3.0% -€1.93M -58.9% -868.9% +12 pp -€1.66M -6.4% -748.5% +0.27 pp
    €228.88K -59.1% -€4.69M +119.7% -2,051.1% -17 pp -€1.78M +68.9% -775.8% -5.9 pp
    €560.01K +∞% -€2.14M -68.4% -381.5% -3.8 pp -€1.05M -72.3% -187.7% -1.9 pp
    €0.00 +NaN% -€6.76M +46.0% N/A -€3.79M -∞% N/A
    €0.00 -€4.63M N/A €0.00 N/A

    Notifications